Laurent Choppe

Laser Based Liposuction & Stem Cells Isolation for enhanced fat grafting & other non aesthetics clinical applications

HeroKi, is an Israeli start-up founded in 2017, dedicated to the development of a unique kidney wearable for post-transplant kidney recipients.

Established in June 2011 and inspired by the vision of President Shimon Peres, Israel Brain Technologies (IBT) is a non-profit organization whose mission is to accelerate brain-related innovation and commercialization. IBT serves as an international hub for the braintech ecosystem. IBT operates several flagship programs, including the international BrainTech conference in Tel Aviv, Brainnovations - a braintech startup launchpad, and Braingels - an international braintech investor network.

Laser Based Liposuction & Stem Cells Isolation for enhanced fat grafting & other non aesthetics clinical applications

HeroKi, is an Israeli start-up founded in 2017, dedicated to the development of a unique kidney wearable for post-transplant kidney recipients.

Established in June 2011 and inspired by the vision of President Shimon Peres, Israel Brain Technologies (IBT) is a non-profit organization whose mission is to accelerate brain-related innovation and commercialization. IBT serves as an international hub for the braintech ecosystem. IBT operates several flagship programs, including the international BrainTech conference in Tel Aviv, Brainnovations - a braintech startup launchpad, and Braingels - an international braintech investor network.

With over USD $10.5B in completed transactions value, Cukierman & Co. is one of the largest Corporate Finance teams in Israel with dedicated experts in the Life Sciences, High Tech, and Real Estate industries. We advise primarily on M&A, Private Placements and Secondary transactions, supported by our network of 12 foreign offices across Europe, Asia and the Americas. Our Private Equity activities are managed by Catalyst Fund, which ranks among the best performing Israeli private equity funds since 1999. Catalyst invests in late-stage Israeli-related technology companies. In 2023, Cukierman & Co. celebrated its 30th anniversary, the final closing of Catalyst IV fund ($150m AUM), and the launch of Catalyst Investors’ Club, a crowdfunding platform that provides accredited investors with access to unique deal flow, currently available only to venture capital community. Cukierman & Co. Investment House and Catalyst Fund have been holding the GoforIsrael Investment Conference (www.goforisrael.com) annually for over 25 years in Israel and abroad. GoforIsrael is one of the most prestigious business conferences in Israel, focusing on the technologies that made Israel famous.

Established in 2006, Cukierman & Co. Life Sciences (CLS) which constitutes CIH’s largest Investment Banking Practice, provides financial advisory services to private and public companies, at different stages of development, across the whole healthcare spectrum, in Israel, Europe, Asia and America with strategic partners. Cukierman & Co. Life Sciences mission is to assist: Biotechnology, pharmaceuticals, diagnostics, medical devices, artificial intelligence and digital health companies in identifying, negotiating and closing equity and venture debts, licensing agreements, strategic partnerships and M&A transactions; We support venture capital & private equity funds, private investors & family offices, corporate funds & corporate development teams, in selecting, evaluating, acquiring and divesting assets, businesses and companies in all life sciences sectors. CLS talented team of scientific, medical, finance and business experts, jointly with our extensive international network, provides corporate guidance and global industry knowledge for fundraising and financial transactions.